Clinical Trials Browser

OTHER × Expanded_access × pembrolizumab × Clear all

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma